Buscar
180 Life Sciences Corp
ATNFWAñadir a la lista de seguimiento
0.430USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de 180 Life Sciences Corp Compañía
180 Life Sciences Corp. is focused on developing new technologies across multiple sectors. The Company is focused on iGaming sector, through its iGaming Technology Platform. The Company also continues to evaluate monetization strategies for its biotechnology assets.
Información de 180 Life Sciences Corp
Símbolo de cotizaciónATNFW
Nombre de la empresa180 Life Sciences Corp
Fecha de salida a bolsaJun 07, 2017
Director ejecutivoMr. Blair Jordan
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección3000 El Camino Real
CiudadPALO ALTO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94306
Teléfono16505070669
Sitio Webhttps://180lifesciences.com/
Símbolo de cotizaciónATNFW
Fecha de salida a bolsaJun 07, 2017
Director ejecutivoMr. Blair Jordan
Ejecutivos de 180 Life Sciences Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Ms. Crystal Heter
Ms. Crystal Heter
Independent Director
Independent Director
--
--
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
--
--
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
--
--
Mr. Jason G. New
Mr. Jason G. New
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Ms. Crystal Heter
Ms. Crystal Heter
Independent Director
Independent Director
--
--
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
--
--
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de 180 Life Sciences Corp?
Los cinco principales accionistas de 180 Life Sciences Corp son: Mr. John T. Saunders